Related Experiment Video
Updated: May 15, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
[MRI for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C)]
1Klinik für Radiologie und Nuklearmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Deutschland. peter.hunold@uksh.de
Insights
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a congenital heart disease. Cardiac MRI is crucial for diagnosing ARVD/C by assessing right ventricular function and structure, aiding in risk stratification.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Context:
- Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a genetic heart condition.
- Sudden cardiac death can be the initial presentation of ARVD/C.
- Diagnosis relies on modified Task Force criteria integrating imaging, ECG, and patient history.
Purpose:
- To evaluate the role of cardiac magnetic resonance imaging (MRI) in diagnosing ARVD/C.
- To highlight MRI's capabilities in assessing right ventricular (RV) structure and function.
- To emphasize MRI's utility in detecting RV aneurysms and myocardial tissue characterization.
Summary:
- Cardiac MRI is the gold standard for RV imaging, providing precise measurements of RV size and function.
- MRI can non-invasively identify fatty and fibrous myocardial replacement, characteristic of ARVD/C.
- While not definitive alone, MRI is an indispensable tool within the ARVD/C diagnostic algorithm.
Impact:
- Cardiac MRI significantly enhances the diagnostic accuracy of ARVD/C.
- It provides critical information for risk stratification and management of patients with ARVD/C.
- Expert interpretation and standardized protocols are essential for optimal diagnostic yield.
Abstract:
Arrhythmogenic right ventricular dysplasia/cardiomyopathy is a congenital disease that may present with sudden cardiac death as the first manifestation. Standards for the difficult clinical diagnosis are the so-called modified Task Force criteria that incorporate imaging-based, electrocardiographic and anamnestic information. Cardiac magnetic resonance imaging (MRI) is the standard technique for imaging of the right ventricle and can compliment the recent ARVD/C diagnosis criteria by providing exact information on right ventricular size and function. It is the most reliable modality available for the detection of right ventricular aneurysms and the quantification of ventricular size. Furthermore, MRI is able to identify areas of fatty or fibrous replacement within the right ventricular myocardium in a non-invasive way. However, a suspicion of ARVD/C cannot be confirmed or excluded based on MRI findings alone. In clinical routine cardiac MRI is an enormously important component in the ARVD/C diagnostic toolbox; however, MRI can only act as one part of the diagnostic puzzle and should exclusively be performed by experienced centers using specifically tailored protocols.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy IV: Restrictive Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
